Startup Funding News
Explore funding rounds, the companies behind them and the investors taking part.
- Rounds
- 4,739 Jan 1 – Oct 27, 2026
- Disclosed funding
- $340.5B 3684 disclosed amounts
- Median round
- $14.4M Of disclosed amounts
| Company | Amount | Round | Sector | Country | Investors | Announced |
|---|---|---|---|---|---|---|
| NL Neural Labs AfricaCompany profile Nairobi healthtech company developing NeuralSight, a medical-imaging platform with image management, AI screening and tele-radiology. Nairobi healthtech company developing NeuralSight, a medical-imaging platform with image management, AI screening and tele-radiology. | $5K | AI Academy Kenya Pitchathon prizeUndisclosed | Healthtech | Kenya | Investors | |
| UH Unravel HealthCompany profile Unravel Health develops saliva-based hormone monitoring for use at home. Unravel Health develops saliva-based hormone monitoring for use at home. | >£2M | First closeUndisclosed | Healthtech | United Kingdom | Investors | |
| F FlagCompany profile Flag provides digital marketing and creative services for the entertainment industry. Flag provides digital marketing and creative services for the entertainment industry. | Undisclosed | Strategic investmentUndisclosed | Media & gaming | Japan | Investors | |
| BI Beff Inc.Company profile A software and laboratory platform for battery developers to connect material, design, test and manufacturing data. A software and laboratory platform for battery developers to connect material, design, test and manufacturing data. | ~¥300M | Series A final closeSeries A | Industrial tech | Japan | Investors | |
 RapidCanvasCompany profile RapidCanvas builds and operates custom enterprise AI applications using a software platform and field engineering teams. RapidCanvas builds and operates custom enterprise AI applications using a software platform and field engineering teams. | $29M | Series B | AI | United States | Investors | |
 Estuary BiotherapeuticsCompany profile Estuary Biotherapeutics develops locally delivered gene therapies for patients with inherited polycystic kidney disease. Estuary Biotherapeutics develops locally delivered gene therapies for patients with inherited polycystic kidney disease. | $93M | Series A | Biotech | United States | Investors | |
| R RSYNQCompany profile RSYNQ develops middleware that connects AI instructions with robots, sensors and other physical systems. RSYNQ develops middleware that connects AI instructions with robots, sensors and other physical systems. | $2M | Strategic investmentUndisclosed | Robotics | United States | Investors | |
| N NEXTESCompany profile NEXTES develops battery-management technology and stationary energy-storage systems. NEXTES develops battery-management technology and stationary energy-storage systems. | ¥2B | Syndicated term loanUndisclosed | Climate tech | Japan | Investors | |
 CapGridCompany profile CapGrid manages sourcing, manufacturing, quality assurance and delivery of precision components for industrial customers. CapGrid manages sourcing, manufacturing, quality assurance and delivery of precision components for industrial customers. | ₹462.8M | Pre-Series BSeries B | Industrial tech | India | Investors | |
| SC STAR CollectionCompany profile STAR Collection produces virtual singers and operates a 3D live platform for their music performances. STAR Collection produces virtual singers and operates a 3D live platform for their music performances. | Undisclosed | Equity financingUndisclosed | Media & gaming | Japan | Investors |
Active investors in this selection
All investors →Ranked by rounds participated in · From Jan 1, 2026
- 1Y Combinator (YC)
BioStack, Tractian, Blacksmith
161rounds5led - 2Andreessen Horowitz (a16z)
ASI, Eka Robotics, Town
111rounds21led - 3General Catalyst
Matiks, Provision Labs, Tractian
102rounds13led - 4Lightspeed
Warp Sciences, Different, Zenzap
80rounds9led - 5Sequoia Capital
Nevis, Warhound, Whop
72rounds13led
Latest digests
Archive →Explore published rounds while the next edition is being prepared.
Browse rounds by topic
Geography
Featured selections
Nordic Foodtech Fund II pairs early capital with scientific expertise
An EIF pledge of up to €30m supports a fund targeting €80m for science-led agrifood companies.
Read the research →